In the end, Nymex members and shareholders approved their acquisition by the CME Group, with 78% voting in favor of the merger, exceeding the 75% minimum required. The deal closed on Friday, August 22. The deal consolidates more than 98% of the US futures market at CME. With more than 60% of Nymex shareholders requesting CME stock, the stock was over subscribed. They will receive $7.29 in cash and 0.2164 shares of CME Group Class A common stock, plus additional cash in lieu of any fractional shares. Those requesting cash received $81.16 per Nymex share. Members also retain the right to use or lease their memberships for Nymex open outcry and electronic trading purposes.